trial
as of 2026-07-01Sex, Psychopharmacology, and Diabetes
NCTId NCT05951660
at a glance
— · Recruiting
Enrollment 256 (estimated)
Sponsored by Zealand University Hospital
Primary completion 2025-07-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
256 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2023-08-24
Primary completion
2025-07-31
Eligibility
ALL · 18 Years
Interventions & indications
Indications
Treatment Adherence and ComplianceDrug-Related Side Effects and Adverse ReactionsSexual Dysfunction, PhysiologicalEducationSchizophrenia Spectrum and Other Psychotic DisordersSchizophrenia Spectrum and Other Psychotic DisordersDiabetes MellitusDiabetes MellitusSchizophreniaSexual DysfunctionSchizophreniaPreDiabetes
Sponsors
Zealand University HospitalLead Sponsor
Steno Diabetes Center SjaellandCollaborator
University College CopenhagenCollaborator
Investigators
5
Gesche Jürgens, Clinical ProfessorStudy Chair
Annamaria Giraldi, Clinical ProfessorPrincipal Investigator
Lise Tarnow, MD, DMScPrincipal Investigator
Charlotte Bredahl Jacobsen, Senior Researcher, PhD.Principal Investigator
Rikke Meyer, MDPrincipal Investigator
Sites
1 total
Slagelse, Denmark
Facts & assertions
4 sourced
Enrollment
256
Phase
NA
Primary Completion Date
2025-07-31
Status
RECRUITING
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
indication
indication
investigator